330 related articles for article (PubMed ID: 25218488)
1. Influence of disintegrants in different substrate physical form on dimensional recovery of multi-component tablet.
Sarkar S; Ooi SM; Liew CV; Tan BX; Heng PW
Int J Pharm; 2014 Nov; 475(1-2):558-65. PubMed ID: 25218488
[TBL] [Abstract][Full Text] [Related]
2. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
3. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
Mehta S; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of disintegrants functionality for orodispersible mini tablets.
Soulairol I; Chaheen M; Tarlier N; Aubert A; Bataille B; Sharkawi T
Drug Dev Ind Pharm; 2017 Nov; 43(11):1770-1779. PubMed ID: 28581832
[TBL] [Abstract][Full Text] [Related]
5. A Simple and Inexpensive Image Analysis Technique to Study the Effect of Disintegrants Concentration and Diluents Type on Disintegration.
Berardi A; Bisharat L; Blaibleh A; Pavoni L; Cespi M
J Pharm Sci; 2018 Oct; 107(10):2643-2652. PubMed ID: 29935295
[TBL] [Abstract][Full Text] [Related]
6. Simplified formulations with high drug loads for continuous twin-screw granulation.
Meier R; Thommes M; Rasenack N; Krumme M; Moll KP; Kleinebudde P
Int J Pharm; 2015 Dec; 496(1):12-23. PubMed ID: 26024821
[TBL] [Abstract][Full Text] [Related]
7. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
[TBL] [Abstract][Full Text] [Related]
8. Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.
Zaheer K; Langguth P
Drug Dev Ind Pharm; 2018 Mar; 44(3):444-451. PubMed ID: 29098885
[TBL] [Abstract][Full Text] [Related]
9. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
Rasool BK; Fahmy SA; Galeel OW
Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
[TBL] [Abstract][Full Text] [Related]
10. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
Meka VS; Yee P; Sheshala R
Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
[TBL] [Abstract][Full Text] [Related]
11. Assessment of disintegrant efficacy with fractal dimensions from real-time MRI.
Quodbach J; Moussavi A; Tammer R; Frahm J; Kleinebudde P
Int J Pharm; 2014 Nov; 475(1-2):605-12. PubMed ID: 25234864
[TBL] [Abstract][Full Text] [Related]
12. Investigations into the tensile failure of doubly-convex cylindrical tablets under diametral loading using finite element methodology.
Podczeck F; Drake KR; Newton JM
Int J Pharm; 2013 Sep; 454(1):412-24. PubMed ID: 23834836
[TBL] [Abstract][Full Text] [Related]
13. Performance of tablet disintegrants: impact of storage conditions and relative tablet density.
Quodbach J; Kleinebudde P
Pharm Dev Technol; 2015; 20(6):762-8. PubMed ID: 24848093
[TBL] [Abstract][Full Text] [Related]
14. Functionality of disintegrants with different mechanisms after roll compaction.
Berkenkemper S; Keizer HL; Lindenberg M; Szepes A; Kleinebudde P
Int J Pharm; 2020 Jun; 584():119434. PubMed ID: 32439584
[TBL] [Abstract][Full Text] [Related]
15. Development of polymer-bound fast-dissolving metformin buccal film with disintegrants.
Haque SE; Sheela A
Int J Nanomedicine; 2015; 10 Suppl 1(Suppl 1):199-205. PubMed ID: 26491321
[TBL] [Abstract][Full Text] [Related]
16. The influence of ethanol on superdisintegrants and on tablets disintegration.
Bisharat L; AlKhatib HS; Muhaissen S; Quodbach J; Blaibleh A; Cespi M; Berardi A
Eur J Pharm Sci; 2019 Mar; 129():140-147. PubMed ID: 30630089
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of manufacturing process parameters causing multilayer tablets delamination.
Bellini M; Walther M; Bodmeier R
Int J Pharm; 2019 Oct; 570():118607. PubMed ID: 31421200
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of different fast melting disintegrants by means of a central composite design.
Di Martino P; Martelli S; Wehrlé P
Drug Dev Ind Pharm; 2005 Jan; 31(1):109-21. PubMed ID: 15704862
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of binders in twin-screw wet granulation - Optimal combination of binder and disintegrant.
Köster C; Kleinebudde P
Eur J Pharm Biopharm; 2023 May; 186():55-64. PubMed ID: 36913991
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet.
Adeoye O; Alebiowu G
Acta Pol Pharm; 2014; 71(5):803-11. PubMed ID: 25362809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
